FNP Pharmacology Review: High-Yield Drugs and Practice Questions

Pharmacology · 5 min read · June 19, 2026

FNP Pharmacology Review: High-Yield Drug Classes, Safety Pearls, and Practice Questions

Pharmacology can feel like one of the most overwhelming parts of FNP board preparation. There are thousands of medications, countless interactions, and seemingly endless adverse effects to remember.

Fortunately, successful pharmacology preparation is not about memorizing an entire drug reference. It is about recognizing clinical patterns and selecting the safest, most appropriate treatment for the patient in front of you.

Official FNP certification blueprints integrate pharmacology into assessment, planning, implementation, therapeutic selection, monitoring, and patient education. In other words, medication questions are usually clinical decision-making questions—not isolated drug-name trivia. Be sure to download the official content outline that corresponds with your examination and testing date. ANCC has announced that its updated FNP examination outline will take effect October 30, 2026.

Clinical review note: This article was reviewed in June 2026. Medication labeling and clinical guidelines change regularly. This content is educational and is not a substitute for current prescribing information, applicable guidelines, or individualized clinical judgment.

What FNP pharmacology questions are really testing

Most board-style pharmacology questions ask you to do one or more of the following:

Select the most appropriate medication for a specific patient. Identify a contraindication or dangerous interaction. Recognize a serious adverse reaction. Determine which laboratory value should be monitored. Adjust treatment for kidney function, pregnancy, age, or comorbidities. Provide essential patient education. Evaluate whether the medication is working. Choose the safest next step when a patient develops an adverse effect.

A medication that is commonly used may not be appropriate for a particular patient. The board question is often testing whether you noticed the pregnancy, allergy history, abnormal potassium level, declining eGFR, interacting medication, or previous adverse reaction hidden in the clinical stem.

Use the IMPACT framework for every drug class

Instead of creating an enormous list of unrelated facts, study each medication class with the IMPACT framework:

I — Indications: Why would you prescribe it?

M — Mechanism: How does it produce its therapeutic effect?

P — Precautions: When should it be avoided or used cautiously?

A — Adverse effects: Which common and dangerous effects matter most?

C — Checks: What symptoms, vital signs, or laboratory values should be monitored?

T — Teaching: What must the patient know before leaving the visit?

When you can explain each major class using these six categories, you are far more prepared to answer application-based questions.

High-yield cardiovascular medications ACE inhibitors and ARBs

Common examples include lisinopril, enalapril, losartan, and valsartan.

Connect these medications with:

Hypertension Heart failure Albuminuric chronic kidney disease Hyperkalemia Changes in kidney function ACE inhibitor–associated cough Angioedema Fetal toxicity

In nonpregnant patients with diabetes, hypertension, and albuminuria, an ACE inhibitor or ARB is a preferred treatment. Kidney function and potassium should be monitored after initiation and periodically thereafter.

One important nuance: do not convert the phrase “kidney protective in diabetes” into “every patient with diabetes should take an ACE inhibitor.” The indication depends on the patient’s blood pressure, albuminuria, kidney function, and other clinical factors.

Diuretics

Know the major differences between the classes:

Thiazide diuretics, such as hydrochlorothiazide and chlorthalidone, may cause hypokalemia, hyponatremia, hyperuricemia, and changes in glucose levels.

Loop diuretics, such as furosemide, are powerful volume-reducing medications. Monitor volume status, kidney function, sodium, and potassium.

Potassium-sparing diuretics and mineralocorticoid receptor antagonists may increase potassium. The risk becomes more important when they are combined with other medications that raise potassium.

Board questions frequently give you the medication list and laboratory results together. Never evaluate either one in isolation.

Calcium channel blockers

Divide these into two groups:

Dihydropyridines, such as amlodipine and nifedipine, act primarily on vascular smooth muscle. Common adverse effects include peripheral edema, flushing, and headache.

Nondihydropyridines, such as diltiazem and verapamil, have greater effects on heart rate and conduction. Watch for bradycardia, heart block, and constipation, particularly with verapamil.

A useful—but not perfect—memory pattern is:

“-dipine” medications are more vascular. Diltiazem and verapamil are more cardiac. Beta blockers

Know which agents are cardioselective and which are nonselective. Nonselective beta blockers can worsen bronchospasm in susceptible patients, while beta blockers may be important for conditions such as certain arrhythmias, ischemic heart disease, and heart failure.

The safest answer depends on the drug, indication, pulmonary history, heart rate, and comorbidities. Avoid broad rules such as “every beta blocker is contraindicated in every patient with COPD.”

Statins

Common examples include atorvastatin, rosuvastatin, and simvastatin.

High-yield concepts include:

Myalgia and muscle weakness Myopathy and rhabdomyolysis warning signs Drug interactions Baseline hepatic assessment Appropriate statin intensity Patient-specific cardiovascular risk

Baseline ALT measurement is recommended before beginning therapy. Routine CK testing is not required for every asymptomatic patient; CK should be evaluated when clinically indicated, particularly when muscle symptoms occur. Severe muscle weakness, dark urine, or systemic symptoms require prompt evaluation.

Anticoagulants

For warfarin, remember:

Regular INR monitoring Bleeding risk Numerous drug and dietary interactions The importance of consistency rather than complete avoidance of vitamin K–containing foods

For direct oral anticoagulants, know that kidney function, medication adherence, indication, and interacting medications still matter even though routine INR testing is not used.

Warfarin dosing must be individualized according to INR response, and medication or dietary changes can alter anticoagulation.

High-yield endocrine medications Metformin

Metformin remains a common, effective, and affordable treatment for type 2 diabetes, but it should not be memorized as the automatic first medication for every patient.

Current therapy is individualized based on factors such as cardiovascular disease, heart failure, chronic kidney disease, weight goals, hypoglycemia risk, medication access, and patient preference.

Key board concepts include:

Gastrointestinal adverse effects Gradual titration Possible vitamin B12 deficiency Kidney-function assessment Temporary interruption in selected acute illness or procedure-related circumstances

According to the 2026 ADA Standards of Care, metformin should not be initiated when eGFR is below 45 mL/min/1.73 m² and should be discontinued when eGFR falls below 30 mL/min/1.73 m².

SGLT2 inhibitors

Examples include empagliflozin and dapagliflozin.

Recognize the following:

Cardiovascular and kidney benefits in selected patients Genital mycotic infections Volume depletion Ketoacidosis, which may occasionally occur without extreme hyperglycemia The need for illness and perioperative instructions Agent- and indication-specific kidney thresholds

Do not study this class only as “a diabetes medication.” Its heart and kidney indications are increasingly important. Current empagliflozin labeling includes warnings related to ketoacidosis, volume depletion, and genitourinary infections.

GLP-1 receptor agonists

Examples include semaglutide and liraglutide.

Know the major themes:

Gastrointestinal adverse effects Gradual dose escalation Weight and glucose effects Hypoglycemia risk when combined with insulin or insulin secretagogues Agent-specific warnings and contraindications

For medications carrying a thyroid C-cell tumor warning, a personal or family history of medullary thyroid carcinoma or MEN 2 is a major contraindication. Always associate this warning with the specific product label rather than assuming every drug has identical labeling.

Sulfonylureas and insulin

The central safety issue is hypoglycemia.

For insulin, understand:

Rapid-, short-, intermediate-, and long-acting categories Which formulations have a pronounced peak Meal timing Sick-day management Hypoglycemia recognition and treatment Patient-specific dose adjustment

For sulfonylureas, consider the patient’s age, meal consistency, kidney function, and risk of prolonged hypoglycemia.

Levothyroxine

Levothyroxine questions often test administration and monitoring rather than mechanism.

Patients should generally take it:

On an empty stomach Approximately 30 to 60 minutes before breakfast Consistently from day to day At least four hours apart from calcium, iron, and other products that interfere with absorption

TSH and clinical response are monitored after initiation and dosage changes.

High-yield antibiotics and anti-infective safety

Before choosing an antibiotic, ask:

Is an antibiotic actually indicated? What is the likely organism? What is the infection site? What does the allergy history truly describe? Does the medication require kidney adjustment? Is the patient pregnant? Are there important medication interactions? Should a culture be obtained? What do current local and national recommendations advise? Penicillins and cephalosporins

Do not treat every “penicillin allergy” label as equivalent.

Diarrhea, nausea, a family history of allergy, a remote nonspecific rash, anaphylaxis, and Stevens-Johnson syndrome represent very different levels of risk. The CDC reports that many recorded penicillin allergies are not true allergies, and cross-reactivity with third-generation cephalosporins is low. Severe immediate reactions and severe cutaneous reactions still require special caution and appropriate evaluation.

Macrolides

Examples include azithromycin and clarithromycin.

Remember:

QT prolongation Gastrointestinal adverse effects Drug interactions Resistance considerations

Clarithromycin is contraindicated with simvastatin and lovastatin because it can significantly increase the risk of myopathy and rhabdomyolysis.

Fluoroquinolones

Examples include ciprofloxacin and levofloxacin.

Important safety concerns include:

Tendon injury Peripheral neuropathy Central nervous system effects Dysglycemia QT effects Aortic aneurysm or dissection risk in susceptible patients

The FDA advises reserving systemic fluoroquinolones for certain uncomplicated infections when reasonable alternatives are unavailable because serious and potentially disabling effects may outweigh the benefits.

Tetracyclines

Doxycycline can cause photosensitivity and esophageal irritation, and its absorption can be reduced by products containing polyvalent cations such as iron, magnesium, and aluminum.

Avoid relying on the blanket rule that doxycycline can never be used in children younger than eight. For suspected Rocky Mountain spotted fever and other rickettsial diseases, the CDC recommends doxycycline for patients of all ages because delayed or ineffective treatment can be dangerous.

Trimethoprim-sulfamethoxazole

Connect this medication with:

Serious skin reactions Kidney-function considerations Hyperkalemia Warfarin interaction Potential blood-count abnormalities

Trimethoprim-sulfamethoxazole may increase INR in patients taking warfarin and can raise potassium, particularly in patients with kidney impairment or those taking other potassium-increasing medications.

High-yield respiratory medications Asthma medications

Know the difference between:

A reliever A controller Maintenance-and-reliever therapy Treatment of an acute exacerbation

Current GINA guidance emphasizes that patients with asthma should receive inhaled corticosteroid–containing therapy. A short-acting beta agonist relieves bronchospasm but does not treat the underlying airway inflammation. LABAs should not be used alone as regular asthma controller therapy.

For inhaled corticosteroids, remember to teach patients to rinse their mouth after use to reduce local adverse effects such as oral candidiasis.

Also assess inhaler technique before assuming the medication has failed. Poor technique and poor adherence are common explanations for inadequate control.

COPD medications

Know the clinical roles of:

Short-acting bronchodilators Long-acting muscarinic antagonists Long-acting beta agonists Inhaled corticosteroids in selected patients

Asthma and COPD medication strategies are not interchangeable. Current GOLD guidance should be used for COPD treatment selection and escalation.

Additional medication areas not to ignore NSAIDs

NSAIDs may contribute to:

Gastrointestinal irritation or bleeding Kidney injury Fluid retention Worsening hypertension Medication interactions

Pregnancy questions require particular attention. The FDA recommends limiting NSAID use between approximately 20 and 30 weeks of pregnancy and avoiding it after 30 weeks unless specifically directed because of fetal kidney and amniotic-fluid risks, in addition to later ductal concerns.

Psychiatric medications

For SSRIs and SNRIs, know:

Delayed therapeutic effect Serotonin syndrome Discontinuation symptoms Sexual adverse effects Hyponatremia risk Suicidality monitoring in younger populations

For benzodiazepines, consider sedation, dependence, respiratory effects, falls, and the risks of combining them with other central nervous system depressants.

Older-adult pharmacology

Always consider:

Reduced kidney clearance Polypharmacy Orthostatic hypotension Falls Anticholinergic burden Hypoglycemia Cognitive effects Whether the medication still has a clear indication

The board question may not ask, “Which medication is inappropriate?” It may instead describe new confusion, falls, constipation, or urinary retention and expect you to identify the likely medication cause.

Common pharmacology traps to avoid

Do not memorize these outdated or overly broad statements:

“Metformin is always the first medication for type 2 diabetes.” “Every reported penicillin allergy means no cephalosporins.” “Doxycycline is never given to a child younger than eight.” “Every patient taking a statin needs routine CK and liver panels.” “Albuterol alone is adequate long-term asthma treatment.” “Every adverse effect means the medication must be permanently discontinued.”

The safer approach is to evaluate the individual patient, the severity of the reaction, the specific medication, current labeling, and current clinical guidance.

A practical pharmacology study plan Use a 30-minute daily cycle

Spend approximately:

10 minutes: Recall one drug class from memory using the IMPACT framework. 15 minutes: Complete 10 to 15 board-style questions. 5 minutes: Add missed concepts to an error log.

Your error log should include:

The clinical clue you missed The medication class involved Why your answer was incorrect Why the correct answer was safest One rule you can apply to a future question

For example:

Clue missed: Diabetes, hypertension, and severe albuminuria Rule: Consider an ACE inhibitor or ARB and monitor potassium and kidney function.

Review rationales even when you answer correctly

A correct guess is not mastery.

For every question, explain:

Why the correct answer is correct Why each distractor is incorrect Which change in the clinical stem would make a distractor appropriate

This turns one question into several learning opportunities.

Mix systems as the exam approaches

Early in your preparation, complete focused sets by system or drug class. As the examination approaches, transition to mixed and timed sets so you must identify the relevant system and medication issue without being told the category in advance.

Original FNP pharmacology practice questions Question 1

A 58-year-old man with type 2 diabetes and hypertension takes amlodipine. His blood pressure is 148/88 mm Hg, UACR is 420 mg/g, eGFR is 64 mL/min/1.73 m², and potassium is 4.4 mEq/L. Which medication is the most appropriate addition?

A. Lisinopril B. Propranolol C. Clonidine D. Furosemide

Answer: A. Lisinopril

The combination of diabetes, hypertension, and severely increased albuminuria supports adding an ACE inhibitor or ARB. Monitor kidney function and potassium after initiation.

Question 2

A 67-year-old woman takes metformin for type 2 diabetes. Her eGFR has declined to 28 mL/min/1.73 m² on two measurements. What is the best next action?

A. Continue the current dosage B. Increase the metformin dosage C. Discontinue metformin and select therapy based on her clinical profile D. Add glyburide without changing metformin

Answer: C. Discontinue metformin and select therapy based on her clinical profile

Metformin is contraindicated when eGFR is below 30 mL/min/1.73 m². The replacement regimen should be individualized according to comorbidities, treatment goals, and medication access.

Question 3

A 63-year-old patient takes simvastatin 40 mg nightly. The patient is prescribed clarithromycin for an infection. What is the best action?

A. Begin both medications without changes B. Take simvastatin in the morning and clarithromycin at night C. Reconsider the regimen before treatment begins D. Add coenzyme Q10 and continue both medications

Answer: C. Reconsider the regimen before treatment begins

Clarithromycin and simvastatin are contraindicated together because clarithromycin can substantially increase simvastatin exposure and the risk of myopathy or rhabdomyolysis. An alternative antimicrobial or lipid-management plan should be selected based on the clinical situation.

Question 4

A 22-year-old patient with asthma uses an albuterol inhaler four days per week and is not taking a controller medication. Which change is most appropriate to reduce future exacerbation risk?

A. Continue albuterol alone B. Begin an inhaled corticosteroid–containing regimen C. Begin daily oral prednisone D. Replace albuterol with ipratropium monotherapy

Answer: B. Begin an inhaled corticosteroid–containing regimen

Short-acting bronchodilators relieve bronchospasm but do not treat the underlying airway inflammation. Current GINA recommendations emphasize ICS-containing therapy for people with asthma. The exact regimen depends on age, symptom frequency, severity, access, and applicable guidelines.

Question 5

A 6-year-old child develops a high fever, severe headache, and rash after a recent tick exposure. Rocky Mountain spotted fever is suspected. Which medication should be started empirically?

A. Amoxicillin B. Azithromycin C. Doxycycline D. Trimethoprim-sulfamethoxazole

Answer: C. Doxycycline

Doxycycline is the recommended treatment for suspected Rocky Mountain spotted fever in patients of all ages. Treatment should not be delayed while awaiting confirmatory testing when clinical suspicion is high.

Question 6

A patient takes levothyroxine with breakfast each morning along with an iron supplement and calcium carbonate. The patient’s TSH remains elevated despite reporting perfect adherence. Which instruction is most appropriate?

A. Take all medications together with a high-fiber breakfast B. Take levothyroxine only when hypothyroid symptoms occur C. Take levothyroxine on an empty stomach and separate it from iron and calcium by at least four hours D. Double the levothyroxine dosage without changing administration

Answer: C. Take levothyroxine on an empty stomach and separate it from iron and calcium by at least four hours

Iron and calcium can reduce levothyroxine absorption. Correcting administration should occur before assuming that the medication has failed or automatically increasing the dosage.

Final encouragement

You do not need to know every medication ever manufactured to succeed on your FNP certification exam.

You do need to recognize:

The major drug classes used in primary care The patient factors that change prescribing decisions Dangerous contraindications and interactions Essential monitoring High-priority patient education The safest next step when something goes wrong

Study medications in clinical context, practice retrieving the information, and review the reasoning behind every answer. That approach will help you prepare not only for examination questions, but also for safer prescribing in practice.

Stop rereading pharmacology. Start practicing clinical decisions.

Open our FNP QBank and complete a targeted pharmacology practice set today. Work through the questions under timed conditions, review the rationale for every answer choice, and turn each missed question into a rule you can use on the next case. START MY PHARMACOLOGY PRACTICE SET →

Practice questions are original educational content and are not recalled examination questions. This resource is not affiliated with or endorsed by ANCC or any nurse practitioner certifying organization.